Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Travere Therapeutics Inc
NASDAQ:TVTX
Travere Therapeutics Inc
NASDAQ:TVTX
Price:
52.04
USD
0.1%
Market Closed
Market Cap:
$4.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently viewed
Price
Wall St Price Targets
TVTX Price Forecast
Based on 16 analysts
Based on 16 analysts
+44% Upside
from
$52.04
today
Travere Therapeutics Inc (TVTX)’s 12-month stock price forecast through November 2027 has a consensus target of $74.97, implying 44% upside. The forecast is based on price targets from 16 Wall Street analysts.
TVTX Analyst Rating
Based on 15 analysts
Based on 15 analysts
Analysts rate TVTX Strong buy, with 14 of 15 recommending Buy or Strong buy.
Travere Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TVTX's stock price target?
Price Target
74.97
USD
74.97
USD
According to Wall Street analysts, the average 1-year price target for TVTX is 74.97 USD with a low forecast of 62.62 USD and a high forecast of 90.3 USD.
What is the Revenue forecast for Travere Therapeutics Inc?
Projected CAGR
22%
22%
The compound annual growth rate for Revenue over the next 8 years is 22%.
What is the Gross Profit forecast for Travere Therapeutics Inc?
Projected CAGR
21%
21%
The compound annual growth rate for Gross Profit over the next 8 years is 21%.
